4.6 Review

Metabolomic Studies in Inner Ear Pathologies

Journal

METABOLITES
Volume 12, Issue 3, Pages -

Publisher

MDPI
DOI: 10.3390/metabo12030214

Keywords

metabolomic; sensorineural hearing loss; perilymph

Funding

  1. Fondation Pour l'Audition [FPA RD 2020-4]

Ask authors/readers for more resources

Sensorineural hearing loss is a common sensory deficit with various etiologies. Metabolomic studies may aid in developing objective tests and personalized treatment for hearing loss.
Sensorineural hearing loss is the most common sensory deficit. The etiologies of sensorineural hearing loss have been described and can be congenital or acquired. For congenital non-syndromic hearing loss, mutations that are related to sites of cochlear damage have been discovered (e.g., connexin proteins, mitochondrial genes, etc.). For cytomegalovirus infection or auditory neuropathies, mechanisms are also well known and well researched. Although the etiologies of sensorineural hearing loss may be evident for some patients, the damaged sites and pathological mechanisms remain unclear for patients with progressive post-lingual hearing loss. Metabolomics is an emerging technique in which all metabolites present in a sample at a given time are analyzed, reflecting a physiological state. The objective of this study was to review the literature on the use of metabolomics in hearing loss. The findings of this review suggest that metabolomic studies may help to develop objective tests for diagnosis and personalized treatment.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available